As the first anti-obesity drug targeting multiple receptors, tirzepatide (Zepbound, Eli Lilly), a dual GIPR/GLP-1R agonist, was approved by the FDA in 2022
It is studied for deepening slow-wave sleep without acting as a sedative a fit for patients whose main complaint is light, fragmented, or unrefreshing sleep
The effect of hydrodistension in combination with pentosan polysulfate on treatment outcomes and compliance in the treatment of bladder pain syndrome
Statistical analysis No statistical methods were used to pre-determine sample sizes, but similar sample sizes were used in previous publications 15,46
Vitamin E and the risk of prostate cancer
Consider: Reduced red meat intake Reduced protein intake Reduced whole grains Reduced vegetable intake Reduced fat intake If YES Intake-related micronutrient risk increases If NO Risk remains lower Step 4: Are Symptoms Present